Dr. Andreas WALLNÖFER Global Head of Development, pRED - Pharma Research & Exploratory Development, F. Hoffmann-La Roche AG, Basel
CV
| Ph.D. at the University of Basel, Post-doc fellowship in Clinical Pharmacology at the University Hospital Leiden, Netherlands; Business training at IMD Lausanne | |
| 1987 | Basic Research, Cardiovascular Discovery Research, Sandoz |
| 1991 | Clinical Investigator, Centre for Human Drug Research, Leiden |
| 1992 | Clinical Pharmacologist, Roche |
| 1996 | Clinical Science and Clinical Team Leader, Cardiovascular Clinical Research, Roche |
| 1999 | Project Leader, R&D Project Management, Roche |
| 2002 | Global Head, Early Development Project Leaders and Project Management, Roche |
| 2007 | Global Head, Clinical Research & Exploratory Development, Roche |
| 2010 | Global Head of Development, Roche Pharma Research & Exploratory Development (pRED) |
Mitgliedschaften
| Roche Pharma R&D leadership team | |
| Research & Exploratory as well as Late stage, Roche Genentech Strategic Portfolio Committees | |
| Expert commission, Swiss Academy of Medical Sciences | |
| Steering Committee of the Singapore Translational Medicine Hub | |
| University of Basel Pharma Center Council |
